A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancer

BACKGROUND: The high cost and the long time required to bring drugs into commerce is driving efforts to repurpose FDA approved drugs—to find new uses for which they weren’t intended, and to thereby reduce the overall cost of commercialization, and shorten the lag between drug discovery and availabil...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hsiao-Rong, Sherr, David H., Hu, Zhenjun, DeLisi, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967295/
https://www.ncbi.nlm.nih.gov/pubmed/27475327
http://dx.doi.org/10.1186/s12920-016-0212-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967295/
https://www.ncbi.nlm.nih.gov/pubmed/27475327
http://dx.doi.org/10.1186/s12920-016-0212-7

Ejemplares similares